ClinicalMetric / Countries / Austria / primary immune thrombocytopenia itp
← 🇦🇹 Austria Trials
🇦🇹 Austria Country × Condition

primary immune thrombocytopenia itp Clinical Trials in Austria

Active clinical trials for primary immune thrombocytopenia itp with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 3 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇦🇹 Austria

Active Trials in Austria (1)

NCT06544499 Phase 3
Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

Enrollment
69 pts
Country
🇦🇹 Austria
argenx
View Trial →

Frequently Asked Questions

How many primary immune thrombocytopenia itp clinical trials are active in Austria?
There are currently 1 active clinical trials for primary immune thrombocytopenia itp with sites in Austria, of which 1 are actively recruiting patients.
How can I join a primary immune thrombocytopenia itp clinical trial in Austria?
To join a primary immune thrombocytopenia itp clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are primary immune thrombocytopenia itp trials in Austria?
Active primary immune thrombocytopenia itp trials in Austria span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Austria Trials → Global primary immune thrombocytopenia itp Trials → All Countries → All Trials →